Literature DB >> 16580083

New multi-step kinetics using common affinity biosensors saves time and sample at full access to kinetics and concentration.

H-H Trutnau1.   

Abstract

Today, affinity-based biosensorics is a standard technology in quantitative biomolecular interaction analysis, but suffers from low sample throughput and sometimes from inaccessible kinetics. A new methodology for such biosensors is introduced here that cuts down measurement time dramatically and increases confidentiality of results. In contrast to traditional applications, the ligand immobilized on the sensor chip is exposed to the binding analyte at a rapid stepwise change of the analyte concentration without the need for regenerations between analyte additions. In the application presented here, each addition of the analyte is succeeded by a buffer flow, yielding alternating association and dissociation phases in a "zigzag" style. This binding curve pattern is analyzed by means of novel fitting algorithms, which render detailed kinetics rate constants at a high level of self-consistency, and hence, validity due to multiple cross-checks. In comparison with traditional sequential kinetics analysis, this new multi-step kinetics approach returns practically identical (or improved) kinetics constants--at valuable savings in time/material since regeneration steps, ligand re-captures, or titration equilibrations are unnecessary.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16580083     DOI: 10.1016/j.jbiotec.2006.01.006

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  3 in total

1.  Aptamers that bind to the human complement component receptor hC5aR1 interfere with hC5aR1 interaction to its hC5a ligand.

Authors:  Penmetcha K R Kumar
Journal:  Mol Biol Rep       Date:  2018-07-06       Impact factor: 2.316

2.  NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies.

Authors:  Sandrine Moutel; Nicolas Bery; Virginie Bernard; Laura Keller; Emilie Lemesre; Ario de Marco; Laetitia Ligat; Jean-Christophe Rain; Gilles Favre; Aurélien Olichon; Franck Perez
Journal:  Elife       Date:  2016-07-19       Impact factor: 8.140

3.  Tripartite split-GFP assay to identify selective intracellular nanobody that suppresses GTPase RHOA subfamily downstream signaling.

Authors:  Laura Keller; Claudine Tardy; Laetitia Ligat; Soazig Le Pennec; Nicolas Bery; Faten Koraïchi; Patrick Chinestra; Mélissa David; Rémi Gence; Gilles Favre; Stéphanie Cabantous; Aurélien Olichon
Journal:  Front Immunol       Date:  2022-08-18       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.